China's Ping An Healthcare H1 revenue profit jumps on corporate client base expansion
China's Ping An Healthcare H1 revenue profit jumps on corporate client base expansion
Overview
China digital health platform's interim H1 revenue fell 0.7% yr/yr to RMB2.48 bln
Profit attributable to shareholders rose 63.5% yr/yr to RMB219 mln
Adjusted net profit increased 37.7% yr/yr, driven by improved business quality and revenue mix
Outlook
Ping An Healthcare plans to use HK$544.9 mln of unutilized placing proceeds by Dec 31, 2028 for investments, acquisitions and overseas expansion
Result Drivers
CORPORATE HEALTH MANAGEMENT - Revenue from corporate health management rose 65.1% yr/yr with the segment accounting for a greater share of total revenue, driven by expansion of the corporate client base and product diversification
AI AND TECHNOLOGY INVESTMENT - Company said ongoing investment in AI and digital operations improved service efficiency and contributed to gross profit growth
INSURANCE + HEALTH CARE SYNERGY - Upgrades to the insurance + health care synergistic model and expanded membership benefits supported customer retention and product competitiveness
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
H1 Revenue |
| RMB 2.48 bln |
|
H1 Net Income Attributable |
| RMB 219.30 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", 5 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Ping AN Healthcare and Technology Co Ltd is HK$14.50, about 95.9% above its August 17 closing price of HK$7.40
The stock recently traded at 25 times the next 12-month earnings vs. a P/E of 41 three months ago
Reuters Recommended Reads
Aug 17 - China Medical System H1 revenue rises on jump in sales of innovative and exclusive products
Aug 17 - Vaccine maker Sinovac H1 revenue rises on overseas growth, approvals
Aug 17 - Mobile healthcare provider DocGo's Q2 revenue misses on wind-down of migrant programs
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Ping An Healthcare and Technology
See all newsChina's Ping An Healthcare H1 revenue profit jumps on corporate client base expansion
Brief: Ping AN Healthcare and Technology Posts H1 Net Income Attributable RMB 219.3 Mln
Brief: Morgan Stanley’s Long Position In Ping An Healthcare And Technology Decreases To 5.88% On June 25 From 8.02%, HKEX Shows
Brief: Ping An Healthcare And Technology Appoints Qin Xu As CFO
Brief: Ping An Healthcare And Technology's 9M Adjusted Net Profit Increases 45.7% To RMB216.1 Mln